- Home
- FSHP vs INCR Comparison
FSHP vs INCR Comparison
Compare FSHP & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- INCR
- Stock Information
- Founded
- FSHP 2018
- INCR 1994
- Country
- FSHP United States
- INCR Israel
- Employees
- FSHP N/A
- INCR N/A
- Industry
- FSHP
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- INCR Health Care
- Exchange
- FSHP NYSE
- INCR Nasdaq
- Market Cap
- FSHP 92.2M
- INCR 83.9M
- IPO Year
- FSHP 2024
- INCR N/A
- Fundamental
- Price
- FSHP $10.42
- INCR $1.48
- Analyst Decision
- FSHP
- INCR
- Analyst Count
- FSHP 0
- INCR 0
- Target Price
- FSHP N/A
- INCR N/A
- AVG Volume (30 Days)
- FSHP 173.0
- INCR 7.7K
- Earning Date
- FSHP 01-01-0001
- INCR 05-01-2025
- Dividend Yield
- FSHP N/A
- INCR N/A
- EPS Growth
- FSHP N/A
- INCR N/A
- EPS
- FSHP 0.21
- INCR N/A
- Revenue
- FSHP N/A
- INCR $65,575,323.00
- Revenue This Year
- FSHP N/A
- INCR $69.54
- Revenue Next Year
- FSHP N/A
- INCR $41.75
- P/E Ratio
- FSHP $48.99
- INCR N/A
- Revenue Growth
- FSHP N/A
- INCR N/A
- 52 Week Low
- FSHP $9.99
- INCR $1.17
- 52 Week High
- FSHP $10.54
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- INCR 45.29
- Support Level
- FSHP N/A
- INCR $1.46
- Resistance Level
- FSHP N/A
- INCR $1.55
- Average True Range (ATR)
- FSHP 0.00
- INCR 0.05
- MACD
- FSHP 0.00
- INCR -0.01
- Stochastic Oscillator
- FSHP 0.00
- INCR 12.50
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.